Labomar

Labomar is a full-service B2B innovation-driven CDMO, producing a wide range of nutraceutical products, medical devices and medical food supplements. The Company was founded in 1998 from the pharmacy of its founder, Mr. Walter Bertin. It has quickly developed and grown to six facilities, 200 customers, 300 employees and 13 registered patents. Headquarted in Treviso, Italy, it was listed on the Italian stock exchange before being de-listed by Charterhouse in September 2023 in partnership with its founder.

Visit: Labomar website